Contrat de protonthérapie finalisé avec Advocate Radiation Oncology Affiliate en Floride 

NEXT STORY
Phathom Pharmaceuticals Announces New Data at ACG 2021 Annual Scientific Meeting
PREV STORY
Turning Point Therapeutics Presents Early Clinical Data for Repotrectinib From Care Study in Pediatric and Young Adult Patients at SIOP 2021 Virtual Congress
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vir Biotechnology to Participate in the Goldman Sachs 42nd Annual Global Healthcare Conference

author_avatar
NASDAQ Market News

Sunesis Pharmaceuticals Announces Presentation of The Ohio State University-Sponsored Preclinical Study of BTK Inhibitor SNS-062 at AACR Annual Meeting

SOUTH SAN FRANCISCO, Calif., April 03, 2017 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) ...

author_avatar
NASDAQ Market News

ElsaLys Biotech announces submission of Biologics License Application to FDA for LEUKOTAC® (inolimomab) for the treatment of graft-versus-host disease in adult patients

author_avatar
NASDAQ Market News